Dr. Ravid Straussman completed a BSc at the Hebrew University Hadassah Medical School. He earned his MSc in Medical Biochemistry and then graduated the MD/PhD program of Hadassah Medical School followed by an MD internship. After completing a short post-doc training period at the lab of Dr. Howard Cedar he joined the lab of Dr. Todd Golub at the Broad Institute of Harvard and MIT for a second postdoc training period where he studied the effects of the tumor microenvironment on chemoresistance. At 2013 he joined the Weizmann Institute as a principal investigator. The Straussman lab studies different aspects of the tumor microenvironment and the tumor microbiome with a special focus on how non-cancer components in the tumor microenvironment can affect the response of cancer cells to cytotoxic, targeted and immune-mediated anti-cancer therapies.
By sarah moreira|2018-12-20T11:12:10+00:00December 5th, 2018|